New molecular entity: Apomorphine injection

News
Article

First therapy approved for “off” episodes in advanced Parkinson’s disease

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
FDA Approves Ajovy for Childhood Migraine Prevention

FDA Approves Ajovy for Childhood Migraine Prevention

Logan Lutton
August 9th 2025
Article

Read More

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

Briana Contreras
August 9th 2025
Podcast

Listen

kitsawet-stock@adobe.com

Valneva Updates Safety Label of Chikungunya Virus Vaccine

Denise Myshko
August 9th 2025
Article

Read More

FDA Approves Presbyopia Treatment, VIZZ

FDA Approves Presbyopia Treatment, VIZZ

Logan Lutton
August 9th 2025
Article

Read More

piter2121-stock.adobe.com

Sarepta to Resume Shipping Elevidys For Ambulatory Duchenne Patients

Denise Myshko
August 9th 2025
Article

Read More

Creative mind-stock@adobe.com

PBM-Offered Genomics Testing Could Reshape Prescribing of Medications

Denise Myshko
August 9th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.